Who are AnaptysBio's investors?

AnaptysBio's investors include BioBrit, Frazier Life Sciences, Biotechnology Value Fund, Norwest Venture Partners, Novo Holdings.

How much funding has AnaptysBio raised?

AnaptysBio has disclosed $40.8M raised across 1 round.

Where is AnaptysBio headquartered?

AnaptysBio is headquartered in San Diego, US.

AnaptysBio

NASDAQ: ANAB

San Diego, US · Founded 2005 · Delaware corporation · 73 employees on LinkedIn · 5 known investors

Find your way into AnaptysBio

AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders. It is a publicly traded biotech company running with fewer than ~10 contractors.

Biotech

Founders & leadership

Robert HoffmanChief Financial Officer2015–2016

Marco LondeiChief Development Officer2014–2020

Hamza SuriaPresident & CEO2011–2022

Daniel FagaPresident, CEO, and Director

Christopher MurphyCFO

Board

Carol GallagherBoard director

Tiba Aynechi Member Board Of Directors2015–2017General Partner at Norwest Venture Partners

James TopperBoard directorManaging Partner at Frazier Life Sciences

John SchmidBoard director

Nicholas LydonBoard director

Hollings RentonBoard director

Investors · 5

BioBritlisted by BioBritLa Jolla

Frazier Life Scienceslisted by Frazier Life SciencesPalo Altovia James N. Topper · board

How we know: Frazier Life Sciences's portfolio page · board seat on SEC Form D · Not right? Tell us

Biotechnology Value FundreportedSan Francisco

How we know: the S-1 prospectus · Not right? Tell us

Norwest Venture PartnersinferredMenlo Park · $10M – $30Mvia Tiba Aynechi · board

How we know: board seat on SEC Form D · Not right? Tell us

Novo HoldingsreportedCopenhagen · $1.1M – $54M

How we know: the S-1 prospectus · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$40.8M disclosed across 1 round · 2015

▶$40.8MraisedJul 2015 · 19 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Robert HoffmanExecutive Officer
Carol GallagherDirector
Marco LondeiExecutive Officer
Tiba AynechiDirector
John SchmidDirector
Nicholas LydonDirector
Hamza SuriaExecutive Officer, Director
Hollings RentonDirector
James TopperDirector

Offering amount: $40.8M
Amount sold: $40.8M
First sale: Jul 2015
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through AnaptysBio went on to found or lead other companies.

Axel BolteBoard ObserverFounded Inozyme Pharma David KingCSOFounded Lassen Therapeutics

Competitors · 5

by search overlap

Fortis Life Sciences25 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.

Eli Lilly25 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Bioworld24 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Aro Biotherapeutics24 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.

Seeking Alpha24 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies competing with AnaptysBio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does AnaptysBio do?: AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders. It is a publicly traded biotech company running with fewer than ~10 contractors.
Who are AnaptysBio's investors?: AnaptysBio's investors include BioBrit, Frazier Life Sciences, Biotechnology Value Fund, Norwest Venture Partners, Novo Holdings.
How much funding has AnaptysBio raised?: AnaptysBio has disclosed $40.8M raised across 1 round.
Where is AnaptysBio headquartered?: AnaptysBio is headquartered in San Diego, US.